AI assistant
INTUITIVE SURGICAL INC — Director's Dealing 2024
Mar 1, 2024
29809_dirs_2024-02-29_b881e0aa-6328-48e2-a886-f08b6f583256.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2024-02-28
Reporting Person: MOHR MARSHALL (Executive VP Global Business S)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-28 | Common Stock | M | 13530 | $242.3367 | Acquired | 40407 | Direct |
| 2024-02-28 | Common Stock | S | 13530 | $385.0805 | Disposed | 26877 | Direct |
| 2024-02-28 | Common Stock | M | 13530 | $177.9867 | Acquired | 40407 | Direct |
| 2024-02-28 | Common Stock | S | 13530 | $385.0805 | Disposed | 26877 | Direct |
| 2024-02-28 | Common Stock | M | 10500 | $166.6233 | Acquired | 37377 | Direct |
| 2024-02-28 | Common Stock | S | 10500 | $385.0805 | Disposed | 26877 | Direct |
| 2024-02-28 | Common Stock | M | 12750 | $174.2567 | Acquired | 39627 | Direct |
| 2024-02-28 | Common Stock | S | 12750 | $385.0805 | Disposed | 26877 | Direct |
| 2024-02-28 | Common Stock | M | 12750 | $139.52 | Acquired | 39627 | Direct |
| 2024-02-28 | Common Stock | S | 12750 | $385.0805 | Disposed | 26877 | Direct |
| 2024-02-28 | Common Stock | M | 22500 | $109.4856 | Acquired | 49377 | Direct |
| 2024-02-28 | Common Stock | S | 14620 | $385.0919 | Disposed | 34757 | Direct |
| 2024-02-28 | Common Stock | M | 22500 | $79.6378 | Acquired | 57257 | Direct |
| 2024-02-28 | Common Stock | S | 13750 | $385.0794 | Disposed | 43507 | Direct |
| 2024-02-28 | Common Stock | M | 11250 | $76.9989 | Acquired | 54757 | Direct |
| 2024-02-28 | Common Stock | S | 6860 | $385.0815 | Disposed | 47897 | Direct |
| 2024-02-28 | Common Stock | M | 10500 | $182.8333 | Acquired | 58397 | Direct |
| 2024-02-28 | Common Stock | S | 10500 | $385.0805 | Disposed | 47897 | Direct |
| 2024-02-29 | Common Stock | M | 2253 | $0.0 | Acquired | 50150 | Direct |
| 2024-02-29 | Common Stock | F | 1142 | $386.59 | Disposed | 49008 | Direct |
| 2024-02-29 | Common Stock | M | 1003 | $0.0 | Acquired | 50011 | Direct |
| 2024-02-29 | Common Stock | F | 509 | $386.59 | Disposed | 49502 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-28 | Non-Qualified Stock Option (right to buy) | $76.9989 | M | 11250 | Disposed | 2026-08-15 | Common Stock (11250) | Direct |
| 2024-02-28 | Non-Qualified Stock Option (right to buy) | $79.6378 | M | 22500 | Disposed | 2027-02-15 | Common Stock (22500) | Direct |
| 2024-02-28 | Non-Qualified Stock Option (right to buy) | $109.4856 | M | 22500 | Disposed | 2027-08-15 | Common Stock (22500) | Direct |
| 2024-02-28 | Non-Qualified Stock Option (right to buy) | $139.52 | M | 12750 | Disposed | 2028-02-15 | Common Stock (12750) | Direct |
| 2024-02-28 | Non-Qualified Stock Option (right to buy) | $166.6233 | M | 10500 | Disposed | 2029-08-15 | Common Stock (10500) | Direct |
| 2024-02-28 | Non-Qualified Stock Option (right to buy) | $174.2567 | M | 12750 | Disposed | 2028-08-15 | Common Stock (12750) | Direct |
| 2024-02-28 | Non-Qualified Stock Option (right to buy) | $177.9867 | M | 13530 | Disposed | 2030-02-28 | Common Stock (13530) | Direct |
| 2024-02-28 | Non-Qualified Stock Option (right to buy) | $182.8333 | M | 10500 | Disposed | 2029-02-15 | Common Stock (10500) | Direct |
| 2024-02-28 | Non-Qualified Stock Option (right to buy) | $242.3367 | M | 13530 | Disposed | 2030-08-28 | Common Stock (13530) | Direct |
| 2024-02-29 | Restricted Stock Units | $0.0 | M | 2253 | Disposed | 2024-02-28 | Common Stock (2253) | Direct |
| 2024-02-29 | Restricted Stock Units | $0.0 | M | 1003 | Disposed | 2026-02-28 | Common Stock (1003) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 100353 | Indirect |
Footnotes
F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 15, 2024.
F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.56 to $386.01 as follows: 9,629 shares sold at $383.56 to $384.54; 57,452 shares sold at $384.59 to $385.59; and 6,479 shares sold at $385.61 to $386.01. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 3,620 shares sold at $383.85 to $384.82; 10,760 shares sold at $384.87 to $385.85; and 240 shares sold at $385.90 to $386.01. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 3,390 shares sold at $383.85 to $384.82; 10,116 shares sold at $384.87 to $385.79; and 244 shares sold at $385.90 to $385.97. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $383.85 to $385.97 as follows: 1,574 shares sold at $383.85 to $384.73; 5,144 shares sold at $384.87 to $385.79; and 142 shares sold at $385.90 to $385.97. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
F7: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
F8: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F9: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.